Nasdaq:US$14.42 (+0.10) | HKEX:HK$22.48 (+0.00) | AIM:£2.22 (+0.06)
Search
Announcements
1234567891011121314151617
18
found Documents: 870
Announcements & Press Releases, Oncology / Immunology | 2 Jul 2007

Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
a070702
Announcements & Press Releases, Regulatory Notice | 22 Jun 2007

Block Admission
a070622
Announcements & Press Releases, Oncology / Immunology | 18 Jun 2007

Chi-Med locks-in property gain and protects low cost R&D structure through acquisition of Shanghai facility
a070618
Announcements & Press Releases, Oncology / Immunology | 23 May 2007

Chi-Med completes patient enrolment on its HMPL-004 ulcerative colitis proof-of-concept; Phase II clinical trial in China
a070523
Announcements & Press Releases, Regulatory Notice | 22 May 2007

Director's Shareholding
a070522
Announcements & Press Releases, Regulatory Notice | 11 May 2007

Results of Annual General Meeting
a070511
Announcements & Press Releases, Regulatory Notice | 12 Apr 2007

Annual Report and Accounts 2006 - Notice of Annual General Meeting
a070412
Announcements & Press Releases, Regulatory Notice | 2 Apr 2007

Board Change
a070402
Announcements & Press Releases, Regulatory Notice | 23 Mar 2007

Director's Shareholding
a070323
Announcements & Press Releases, Group | 21 Mar 2007

Preliminary Results for the year ended 31 December 2006
a070321
Announcements & Press Releases, Regulatory Notice | 26 Feb 2007

Notice of Preliminary Results
a070226
Announcements & Press Releases, Other Ventures | 17 Jan 2007

Related party transaction Chi-Med formalises China Sales and Distribution Arrangements
a070117
Announcements & Press Releases, Regulatory Notice | 5 Jan 2007

Appointment of Joint Broker
a070105
Announcements & Press Releases, Oncology / Immunology | 20 Nov 2006

Chi-Med and Merck KGaA Start Collaboration to Discover Novel Small Molecule Anti-Cancer Drugs
a061120
Announcements & Press Releases, Oncology / Immunology | 6 Nov 2006

Development Agreement with Procter & Gamble for the Discovery and Development of New Active Ingredients for Beauty Products
a061106
Announcements & Press Releases, Regulatory Notice | 29 Sep 2006

Appointment of Senior Independent Director
a060929
Announcements & Press Releases, Group | 9 Aug 2006

Financial Results for the Six Months Ended 30 June 2006
p060809
Announcements & Press Releases, Regulatory Notice | 26 Jul 2006

Notice of Maiden Interim Results
a060726
Announcements & Press Releases, Group | 17 Jul 2006

Trading Update
a060717
Announcements & Press Releases, Oncology / Immunology | 4 Jul 2006

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate
a060704
1234567891011121314151617
18